QV Bioelectronics is pleased to announce that is has been awarded £150,000 in funding from the NIHR (National Institute for Heath Research) Invention for Innovation (i4i) programme. The i4i award will fund additional prototype engineering over the next 12 months. This will help us continue the development of our device which aims to improve the [...]
We are delighted to announce that Dr Nimrah Munir has joined QV as our Principal Biomaterials Scientist. Dr Munir is a bioengineer with expertise in biomaterial production and characterisation. Following on from her undergraduate degree in Applied Pharmacology, where she received The Royal Society of Biology top student award (2015) at Queen Margaret University, Nimrah [...]
QV Bioelectronics are proud to announce the addition of Mr Hani Marcus as a member of our clinical advisory board and our design input group. Hani beings with him a wealth of expertise and experience, he currently acts as an academic consultant neurosurgeon at the National Hospital for Neurology and Neurosurgery. He was among the [...]
Co-Founder Chris won the annual BioCap Call for Pitches 2019 competition. Chris gave an engaging 5-min pitch of the business and how our technological developments at QV aim to help glioblastoma patients. Coming out ahead against 7 other finalists, Chris impressed not only the audience but a panel of experienced judges. "Chris gave a clear [...]
QV is proud to announce that we are joining the world-class RebelBio Accelerator program at Imperial College's White City Campus in London. RebelBio (run by VC-firm SOSV), only accept 1.3% of start-up applicants onto their program, with successful graduates of the program including Perfect Day, Chronomics and Algiknit. As part of the 3-month program, we've [...]
We're excited to announce our new team member, Qasim Akhtar! Qasim is a recent Masters's graduate from the University of Manchester with a background in Biotechnology. Using his scientific background, combined with his experience in previously running consumer businesses, he'll help to drive forward the growth of the business as a Business Development Officer.
Co-Founder and Managing Director Chris Bullock will be joining the Alderley Park Accelerator, which will help provide the tools, methodologies, and approaches that will enable us to further grow the business
QV Bioelectronics has found a new home in Alderley Edge, Cheshire. We're excited to be moving into the Alderley Park Science Park, the UK's largest Bioscience campus. A centre renowned for its state of the art laboratory and workspace, better helping us to achieve our goals in developing innovative cancer therapies. Being part of a [...]
We have changed our name to one that better reflects our mission to develop innovative electrotherapies for cancer You can find us on Twitter @QVBio, on Linkedin, and on Medium @QVBio
The All-Party Parliamentary Group on Brain Tumours has released a report into the economic and social costs of brain tumours to the UK.